- Resources & Guidelines
- Education & Research
- Awards & Bursaries
The ABN gratefully acknowledges the generous support of the following ABN Annual Sponsors for 2019.
Actelion is part of the Johnson & Johnson Family of Companies. We are leaders in the science and medicine of pulmonary arterial hypertension (PAH), with over 15 years of experience in this devastating cardiopulmonary disorder. Actelion UK was established in 2001 and is based to the west of London.
We are a clinical-stage gene therapy company focused on developing novel treatments and ensuring access for patients and families affected by rare and life-threatening neurological genetic diseases. Our goal is to utilise cutting-edge science to deliver a functional copy of a lost or defective gene, using a single-dose delivery method.
At Biogen, our mission is clear: we are pioneers in neuroscience. Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Many people also suffer from less common diseases such as spinal muscular atrophy and progressive supranuclear palsy. We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience. To learn more, please visit https://www.biogen.uk.com
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cuttingedge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the “Merck” name and brand except in the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Novartis UK is a leading medicines company powered by data and digital. Our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to address some of society’s most challenging healthcare issues. Proud to be a leader within the life sciences industry in the UK, we develop breakthrough treatments and deliver them directly to the millions of people in the UK who need them.
Novartis Pharmaceuticals UK Limited
(UK Head Office), Frimley
Frimley Business Park
Frimley, Camberley, Surrey GU16 7SR
Tel: +44 1276 692255
Fax: +44 1276 692508
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Roche in the UK employs over 2,000 people in pharmaceuticals and diagnostics.
We are Teva, a global pharmaceutical company specialising in medicines within the central nervous system and respiratory therapy areas. We’ve been around for about 80 years, which is longer than the NHS! We contribute to improving the lives and health of patients all around the UK. We’re the biggest supplier of medicines to the NHS* and a key partner to NHS organisations where we work together to improve healthcare outcomes for patients through joint working projects. *Data on file
Teva UK Limited, Ridings Point
Whistler Drive, Castleford WF10 5HX
VisitScotland is the national tourism organisation for Scotland. Our main aim is to contribute significantly to the advancement of Scottish tourism by giving it a real presence in the global marketplace and benefiting the whole of Scotland.